Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation

Diabetes

Volumn 47, Issue 10, 1998, Pages 1619-1624

  O'Harte, Finbarr P M ^a   Mooney, Mark H ^a   Kelly, Catherine M N ^a   Flatt, Peter R ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; LEPTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONAL REGULATION; HYPERGLYCEMIA; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SATIETY;

AMINO ACID SEQUENCE; AMINOPEPTIDASES; ANIMALS; BLOOD; EATING; GLYCOSYLATION; MALE; MICE; PEPTIDE FRAGMENTS; SATIATION; SEQUENCE ANALYSIS; SINCALIDE; SORBITOL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031690197     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.10.1619     Document Type: Article

References (50)

1. Ivy AC, Oldberg E: A hormone mechanism for gallbladder contraction and evacuation. Am. J Physiol 65:599-613, 1928
2. Liddle RA: Cholecystokinin. In Gut Peptides Biochemistry and Physiology. Walsh JH, Dockray GJ, Eds, New York, Raven, 1994, p. 175-216
3. Cantor P: Cholecystokinin in plasma. Digestion 42:181-201, 1989
4. Mutt V, Jorpes JE: Structure of porcine cholecystokinin-pancreozymin: cleavage with thrombin and with trypsin. Eur J Biochem 6:156-162, 1968
5. Crawley JN, Corwin RL: Biological actions of cholecystokmin. Peptides 15:731-755, 1995
6. Smith GP: The therapeutic potential of cholecystokinin. Int J Obes Relat Metab Disord 8:35-38, 1984
7. Larsson L-I, Rehfeld JF: Distribution of gastrin and CCK cells in the rat gastrointestinal tract. Histochemistry 58:23-31, 1978
8. Innis RB, Snyder SH: Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci USA 77:6917-6921, 1980
9. Moran TH, Amegliopeter J, Schwarte GJ, McHugh PR: Blockade of type A, but not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am Physiol Soc 262:R46-R49, 1992
10. Shillabeer G, Davison JS: Increased food intake in the rat caused by proglumide, the cholecystokinin antagonist. Ann N Y Acad Sci 48:649-650, 1985
11. Gibbs J, Young RC, Smith GP: Cholecystokinin decreases food intake in rats. J Comp Psychol 84:488-495, 1973
12. Morley JE: Neuropeptide regulation of appetite and weight. Endocr Rev 8:256-287, 1987
13. Silver AJ, Morley JE: Role of CCK in the regulation of food intake. Prog Neurobiol 36:23-34, 1991
14. Smith GP, Jerome C, Norgren R: Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. Am J Physiol 249:R638-R641, 1985
15. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ: Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat Science 213:1036-1037, 1981
16. Hirosue Y, Inui A, Teranishi A, Miura M, Nakajima M, Okita M, Nakajima Y, Himori N, Baba S, Kasuga M: Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice. Am J Physiol 265:R481-485, 1993
17. Melville LD, Greenberg D, Smith GP, Gibbs J, Russ MJ: Intraperitoneally administered CCK-8 acts locally, not hormonally to inhibit food intake (Abstract). Soc Neurosci Abstr 19:816, 1993
18. Zhu XG, Greeley GH, Lewis BG, Lilja P, Thompson JC: Blood-CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK. J Neurosci Res 15:393-403, 1986
19. Bailey CA, Dela-Fera MA: Central nervous system cholecystokinin and the control of feeding. Ann N Y Acad Sci 448:424-429, 1995
20. Smith GP, Gibbs J: The satiety effect of cholecystokinin: recent progress and current problems. Ann N Y Acad Sci 448:417-423, 1985
21. Pappas TN, Melendez RL, Strah KM, Debas HT: Cholecystokinin is not a peripheral satiety signal in the dog. Am J Physiol 249:G733-G738, 1985
22. Pekas JC: Effect of cholecystokinin immunization, enhanced food intake and growth of swine on lean yield and carcass composition. J Nutr 121:563-567, 1991
23. Ebenezer IS, De la Riva C, Baldwin BA: Effects of the CCK receptor antagonist MK-329 on food intake in pigs. Physiol Behav 47:145-148, 1990
24. Wolkowitz OM, Gertz B, Weingartner H, Beccaria L, Thompson K, Liddle RA: Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. Biol Psychiatry 28:169-173, 1990
25. Smith GP, Gibbs J: Are gut peptides a new class of anorectic agents? Am J Clin Nutr 55:283S-285S, 1992
26. Maison CA, Wiater MF, Weigle DS: Leptin and the regulation of body adiposity: a critical review. Diabetes Review 4:488-508, 1996
27. Matson CA, Wiater MF, Kuijer JL, Weigle DS: Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake. Peptides 18:1275-1278, 1997
28. Hunter SJ, Wiggam MI, Boyd AC, O'Harte FPM, Ennis CN, Gamble R, Sheridan B, Barnett CR, McNulty H, Bell PM, Flatt PR: Glycation of human insulin reduces its biological potency as assessed by euglycaemic clamps in normal man (Abstract). Diabet Med 13 (Suppl. 7):S17-S18, 1996
29. O'Harte FPM, Gray AM, Abdel-Wahab YHA, Flatt PR: Effects of non-glycated and glycated glucagon-like peptide-1(7-36) amide on glucose metabolism in isolated mouse abdominal muscle. Peptides 18:1327-1333, 1997
30. O'Harte FPM, Gray AM, Flatt PR: Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated abdominal muscle from mice. J Endocrinol 156:237-243, 1998
31. O'Harte FPM, Højrup P, Barnett CR, Flatt PR: Identification of the site of glycation of human insulin. Peptides 17:1323-1330, 1996
32. Roepstorff P: 252-Californium plasma desorption time-of-flight mass spectrometry of peptides and proteins. Methods Mol Biol 17:229-230, 1993
33. O'Harte FPM, Bookman CS, Abel PW, Conlon JM: Isolation, structural characterization and pharmacological activity of dog neuromedin U. Peptides 12:11-15, 1991
34. Flatt PR, Bailey CJ: Glucose and insulin response to conditioned feeding in lean and genetically obese hyperglycaemic (ob/ob) mice. Metabolism 32:504-509, 1983
35. Gunn I, O'Shea D, Turton MD, Beak SA, Bloom SR: Central gluoagon-like peptide-1 in the control of feeding. Biochem Soc Trans 24:581-584, 1996
36. Drucker DJ: Glucagon-like peptides. Diabetes 47:159-169, 1998
37. Hoffmann P, Eberlein GA, Reeve JR Jr, Bünte RH, Grandt D, Goebell H, Eysselein VE: Comparison of clearance and metabolism of infused cholecystokinin- 8 and 58 in dog. Gastrorenterology 105:1732-1736, 1993
38. Migaud M, Durieux C, Viereck J, Soroca-Lucas E, Fournie-Zaluski M, Rocques BP: The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A. Peptides 17:601-607, 1996
39. Deschodt-Lanckman M, Bui ND, Noyer M, Christophe J: Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography. Regul Pept 2:15-30, 1981
40. Danho W, Makofske RC, Swistok J, Michalewsky J, Gabriel T, Marks N, Berg MJ, Baird L, Geiler V: Synthesis and biological activity of novel potent and long- acting analogues of AC-CCK-7 with high affinity for peripheral type A receptors. Pept Res 4:59-65, 1991
41. Durieux C, Charpentier B, Fellioin B, Gacel G, Pelaprat D, Rocques BP: Mul- tiple cleavage sites of cholecystokinin heptapeptide by enkephalinase. Peptides 6:495-501, 1985
42. Matsas R, Turner AJ, Kenny AJ: Endopeptidase-24.11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of choleoystokinin octapeptide (CCK-8). FEBS Lett 175:124-128, 1984
43. Rose C, Camus A, Schwartz JC: A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain. Proc Natl Acad Sci U S A 85:8325-8330, 1988
44. Dubreuil P, Fulcrand P, Rodriguez M, Fulcrand H, Laur J, Martinez J: Novel activity of angiotensin converting enzyme: hydrolysis of cholecystokinin and gastrin analogues with release of the C-amidated C-terminal dipeptide. Biochem J 262:125-130, 1989
45. Van der Kooy D: Area postrema: site where cholecystokinin acts to decrease food intake. Brain Res 295:345-347, 1984
46. Tritos NA, Mantzoros CS: Leptin: its role in obesity and beyond. Diabetologia 40:1371-1379, 1997
47. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995
48. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM: Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311, 1996
49. Ballinger A, McLoughlin L, Medback S, Clark M: Cholecystokinin is a satiety hormone in humans at physiological post-prandial plasma concentrations. Clin Sci 89:375-381, 1995
50. Rose C, Vargas F, Facchinetli P, Bourgeat P, Bambal RB, Bishop PB, Chan SMT, Moore ANJ, Ganellin CR, Schwartz J-C: Characterization and inhibition of a cholecystokinin-inactivating serine peptidase. Nature 380:403-409, 1996